1448655

Moxifloxacin Related Compound E

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): 1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride, 8-Hydroxy moxifloxacin hydrochloride
• Empirical Formula (Hill Notation): C₂₀H₂₂FN₃O₄ · HCl
• CAS Number: 721970-36-1
• Molecular Weight: 423.87
• MDL number: MFCD20921978
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• Product Name: Moxifloxacin Related Compound E, United States Pharmacopeia (USP) Reference Standard
• SMILES string: Fc1cc2c([n](cc([c]2=O)C(=O)O)C5CC5)c(c1N3C[C@H]4NCCC[C@H]4C3)O
• InChI: 1S/C20H22FN3O4/c21-14-6-12-16(24(11-3-4-11)8-13(18(12)25)20(27)28)19(26)17(14)23-7-10-2-1-5-22-15(10)9-23/h6,8,10-11,15,22,26H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
• InChI key: IRASTQSQRDRSEH-ZUZCIYMTSA-N
• grade: pharmaceutical primary standard
• API family: moxifloxacin
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat

Description

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Moxifloxacin Related Compound E USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Safety Information

• Storage Class: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable